Etrinabdione
Product Sizes
10 mg
£ POA
HY-128872-10MG
5 mg
£ POA
HY-128872-5MG
1 mg
£ POA
HY-128872-1MG
25 mg
£ POA
HY-128872-25MG
50 mg
£ POA
HY-128872-50MG
100 mg
£ POA
HY-128872-100MG
10mM/1mL
£ POA
HY-128872-10MM
About this Product
- SKU:
- HY-128872
- Additional Names:
- EHP-101; VCE-004.8
- CAS Number:
- 1818428-24-8
- Extra Details:
- Etrinabdione (EHP-101; VCE-004.8) is an orally active; specific PPARγ and CB2 receptor dual agonist. Etrinabdione inhibits prolyl-hydroxylases (PHDs) and activates the HIF pathway. Etrinabdione; a semi-synthetic multitarget cannabinoquinoid; has potent anti-inflammatory activity. Etrinabdione attenuates adipogenesis and prevents diet-induced obesity[1][2].
- Molecular Weight:
- 433.58
- Purity:
- 99.16
- References:
- [1]Navarrete C, et al. Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy. J Neuroinflammation. 2018 Mar 1;15(1):64.|[2]Palomares B, et al. VCE-004.8, A Multitarget Cannabinoquinone, Attenuates Adipogenesis and Prevents Diet-Induced Obesity. Sci Rep. 2018 Oct 31;8(1):16092.
- Research Area:
- Metabolic Disease; Inflammation/Immunology
- Shipping Conditions:
- Ambient
- Storage Conditions:
- -20[o]C; 3 years; 4[o]C; 2 years (Powder)
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Small Molecules
- Pathway:
- Cell Cycle/DNA Damage;GPCR/G Protein;Metabolic Enzyme/Protease;Neuronal Signaling;Vitamin D Related/Nuclear Receptor
